REFERENCES
- Barnett J. Developmental immunotoxicology. Experimental Immunotoxicology, R. J. Smialowicz, M. P. Holsapple. CRC Press, Boca Raton, FL 1996; 47–62
- Dietert R. R. Developmental immunotoxicology: Overview of issues including critical windows of development. Reprod. Toxicol. 2003; 17: 478–479, [CSA]
- Greely G. H., Kizer J. S. The effects of chronic methylphenidate treatment on growth and endocrine function in the developing rat. J. Pharmacol. Exp. Ther. 1980; 215: 545–551, [CSA]
- Holsapple M. P., Burns-Naas L. A., Hastings K. L., Ladics G. S., Lavin A. L., Makris S. L., Yang Y., Luster M. I. A proposed testing framework for developmental immunotoxicology (DIT). Toxicol. Sci. 2005; 83: 18–24, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ladics G. S., Chapin R. E., Hastings K. L., Holsapple M. P., Makris S. L., Sheets L. P., Woolhiser M. R., Burns-Naas L. A. Developmental toxicology evaluations—Issues with including neurotoxicity and immunotoxicology assessments in reproductive toxicology studies. Toxicol. Sci. 2005; 88: 24–29, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Pizzi W. J., Rode E. C., Barnhart J. E. Differential effects of methylphenidate on the growth of neonatal and adolescent rats. Neurotoxicol. Teratol. 1987; 9: 107–111, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Rice D., Barone S., Jr. Critical periods of vulnerability for the developing nervous system: Evidence from humans and animal models. Environ. Health Perspect. 2000; 108(Suppl. 3)511–533, [PUBMED], [INFOTRIEVE], [CSA]
- The 1998 Pediatric Rule. Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients; Final Rule. Fed. Reg., 63: 66632–66672, [CSA]
- U.S. Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for Industry on Immunotoxicology Evaluation of Investigational New Drugs. U.S. FDA, Washington, D.C. 2002
- Weaver J. L., Tsutsui N., Hisada S., Vidal J. M., Spanhaak S., Sawada J., Hastings K. L., Van der Laan J. W., van Loveren H., Kawabata T. T., Sims J., Durham S. K., Fueki O., Matula T. I., Kusunoki H., Ulrich P., Nakamura K. Meeting Report: Development of the ICH guidelines for immunotoxicology evaluation of pharmaceuticals using a survey of industry practices. J. Immunotoxicol. 2005; 2: 171–180, [CSA], [CROSSREF]